4-(Chloromethyl)-5-methyl-1,3-dioxol-2-one structure
|
Common Name | 4-(Chloromethyl)-5-methyl-1,3-dioxol-2-one | ||
---|---|---|---|---|
CAS Number | 80841-78-7 | Molecular Weight | 148.544 | |
Density | 1.4±0.1 g/cm3 | Boiling Point | 163.2±42.0 °C at 760 mmHg | |
Molecular Formula | C5H5ClO3 | Melting Point | N/A | |
MSDS | Chinese USA | Flash Point | 66.7±26.9 °C | |
Symbol |
GHS07 |
Signal Word | Warning |
Name | 4-Cloromethyl-5-methyl-1,3-dioxol-2-one |
---|---|
Synonym | More Synonyms |
Density | 1.4±0.1 g/cm3 |
---|---|
Boiling Point | 163.2±42.0 °C at 760 mmHg |
Molecular Formula | C5H5ClO3 |
Molecular Weight | 148.544 |
Flash Point | 66.7±26.9 °C |
Exact Mass | 147.992722 |
PSA | 43.35000 |
LogP | 1.61 |
Vapour Pressure | 2.1±0.3 mmHg at 25°C |
Index of Refraction | 1.481 |
Symbol |
GHS07 |
---|---|
Signal Word | Warning |
Hazard Statements | H302-H315-H319-H335 |
Precautionary Statements | P261-P305 + P351 + P338 |
Personal Protective Equipment | Eyeshields;Faceshields;full-face respirator (US);Gloves;multi-purpose combination respirator cartridge (US);type ABEK (EN14387) respirator filter |
Hazard Codes | Xn: Harmful; |
Risk Phrases | R22 |
Safety Phrases | S26 |
RIDADR | NONH for all modes of transport |
HS Code | 2932999099 |
~10% 4-(Chloromethyl... CAS#:80841-78-7 |
Literature: Sakamoto; Ikeda; Tsukamoto Chemical and Pharmaceutical Bulletin, 1984 , vol. 32, # 6 p. 2241 - 2248 |
~88% 4-(Chloromethyl... CAS#:80841-78-7 |
Literature: Ikeda, Shoji; Takebe, Yasushi; Hirayama, Ryoichi; Sakamoto, Fumio; Iuchi, Koji; Tsukamoto, Goro Chemical and Pharmaceutical Bulletin, 1988 , vol. 36, # 1 p. 394 - 397 |
~1% 4-(Chloromethyl... CAS#:80841-78-7 |
Literature: Chemical and Pharmaceutical Bulletin, , vol. 36, # 1 p. 394 - 397 |
Precursor 2 | |
---|---|
DownStream 9 | |
HS Code | 2932999099 |
---|---|
Summary | 2932999099. other heterocyclic compounds with oxygen hetero-atom(s) only. VAT:17.0%. Tax rebate rate:13.0%. . MFN tariff:6.5%. General tariff:20.0% |
Synthesis and Physicochemical Characterization of the Process-Related Impurities of Olmesartan Medoxomil. Do 5-(Biphenyl-2-yl)-1-triphenylmethyltetrazole Intermediates in Sartan Syntheses Exist?
Molecules 20 , 21346-63, (2015) During the process development for multigram-scale synthesis of olmesartan medoxomil (OM), two principal regioisomeric process-related impurities were observed along with the final active pharmaceutic... |
4-chloromethyl-5-methyl-2-oxo-1,3-dioxolene |
4-(Chloromethyl)-5-methyl-1,3-dioxol-2-one |
4-chloromethyl-5-methyl-1,3-dioxolen-2-one |
MFCD07787494 |
DMDO-CL |
4-ChloroMethyl-5-Methyl-1 |
4-CHLOROMETHYL-5-METHYL-1,3-DIOXOL-2-ONE |
T5OVOJ D1G E1 |
medoxomil chloride |
4-methyl-5-chloro methyl-1,3-dioxol-2-one |
1,3-Dioxol-2-one, 4-(chloromethyl)-5-methyl- |
4-Chloromethyl-5-methyl-1,3-dioxol-2-on |
4-CHLOROMETHYL-5-METHYL-1,3-DIOXOL-3-ONE |
4-CHLOROMETHYL-5-METHYL-2-OXO-1,3-DIOXOLE |
4-Chloromethyl-5-Methyl-1,3-Di |
4-Choromethyl-5-methyl-2-oxo-1,3-dioxole |